Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

00:26 EDT 20th October 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 27,000+

Friday 17th October 2014

OctreoPharm's OPS202 receives FDA orphan drug status for neuroendocrine tumors

German radiopharmaceutical firm OctreoPharm Sciences has received orphan drug designation from the US food and Drug Administration (FDA) for its new radiotracer OPS202, based on a next generation antagonistic somatostatin analog for the management of...

Amir Ansari to Deliver Keynote at SMARTWEEK 2014

Prodea CTO to Discuss Privacy in the Smart Home RICHARDSON, Texas (PRWEB) October 17, 2014 WHAT: Prodea Systems’ Chief Technology Officer and Co-Founder Amir Ansari will deliver a keynote at SMARTWEEK 2014, which explores emerging smart technologies and strategies that are shaping today’s connected world. Amir’s keynote will take place during Industry Day, which brings together top leaders...

Incyte Appoints David Gryska as Executive Vice President and Chief Financial Officer

Incyte Corporation (NASDAQ: INCY) today announced the appointment of David Gryska as Executive Vice President and Chief Financial Officer, effective October 31, 2014. Mr. Gryska will report to Hervé Hoppenot, President and Chief Executive Officer. Mr. Gryska will succeed David Hastings, who has served as Incyte’s Executive Vice President and Ch...

NICE swayed by long term Glivec data

NICE has reversed a long-standing block on using Glivec in GIST tumours, saying new evidence has persuaded it to change its mind.Final draft guidance published today proposes to recommend Novartis' Glivec (imatinib) for up to three years for peo...

Virax to acquire cancer drug developer AKTivate

Biospectrum Virax would pay $300,000 cash and 234 million shares at $0.01 per share for the acquisition [Read more]

Sarepta Therapeutics Climbs on Ebola Vaccine News

Shares of Sarepta Therapeutics jumped 11 percent before the opening bell Friday after the drug developer said its potential Ebola treatment generated no safety concerns in early-stage human testing.The drug has already shown in animal testing that it...

AnthroTronix’s brain health assessment tool obtains FDA approval

Research and development company AnthroTronix has received approval from the US Food and Drug Administration for its brain health assessment tool, DANA.

Roche and Pharmacyclics agree leukaemia pact

Pharmacyclics’s cancer drug Imbruvica will be tested in combination with Roche’s Gazyva in a new partnership announced by the firms. The combined drugs will be evaluated for use in patients with non-Hodgkin lymphoma (NHL) and chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL). Both products are already approved for the treatment of CLL. Imbruvica (ibrutinib) is used in patients...

Nuvo Research jumps on sale of US rights for osteoarthritis drug to Horizon Pharma

Shares of Nuvo Research (TSE:NRI) rallied as much as 17% early Friday after the company sold its US sales and marketing rights for Pennsaid 2% to Horizon Pharma (NASDAQ:HZNP) for US$45 million. Nuvo said it retains all rights for Pennsaid and Pennsai...

Salix Pharmaceuticals Outlines Data Presentations at American College of Gastroenterology 2014 Annual Scientific Meeting

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that presentations related to research of two of the Company’s products are scheduled to take place during the American College of Gastroenterology (ACG) 2014 Annual Scientific Meeting. ACG 2014 is being held in Philadelphia, PA, October 17-22. Rifaximin Paper #45: Lembo e...

FDA facing huge pressure as Ebola worsens

The Food and Drug Administration (FDA) told the US Congress yesterday it is working hard to clarify the framework for bringing experimental therapies and vaccines to patients affected by Ebola, although the agency is facing "incredible demands" as th...

Millennium Treatment Group Joins 14 Days on the Wagon Challenge

The treatment facility encourages everyone to participate in the two-week challenge. Lake Worth, FL (PRWEB) October 17, 2014 Millennium Treatment Group is supporting the 14 Days on the Wagon Challenge, in which participants will cut harmful substances out of their lives for two weeks. This includes alcohol and any non-medically necessary drugs. The Substance Abuse and Mental Health Services Admin...

Anti-cancer nanomedicines with smaller sizes exhibit enhanced performance in vivo, show studies

Nanomedicines consisting of nanoparticles for targeted drug delivery to specific tissues and cells offer new solutions for cancer diagnosis and therapy.

Allergy & Asthma Network Spotlighted In 'Innovations with Ed Begley, Jr.' on Discovery Channel

VIENNA, Va., Oct. 17, 2014 /PRNewswire-USNewswire/ -- Allergy & Asthma Network, a leading nonprofit patient education and advocacy organization, will be featured in the Monday, Oct. 20 episode of "Innovations with Ed Begley, Jr." on the Discovery Channel. The show broadcasts at 7:30 a.m. ET/PT. In the segment, viewers learn how allergens and irritants affect people with asthma and allergies, ...

Chimerix gets FDA OK to test drug for Ebola

(AP)—A North Carolina drugmaker plans to test its experimental antiviral drug in patients who have Ebola, after getting authorization from regulators at the Food and Drug Administration.

Astellas and CoMentis to End Agreement to Collaborate on Research, Development and Commercialization of Beta-Secretase Inhibitors for Alzheimer's Disease

Tokyo, Japan & South San Francisco CA, October 16, 2014 –Astellas Pharma Inc. (TSE: 4503) and CoMentis, Inc. today announced the companies will end their worldwide exclusive collaboration agreement for research, development and commercial...

Paratek Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Paratek Pharmaceuticals, Inc. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 31-page report is available in PDF from $1500. Paratek Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Paratek Pharmaceuticals, Inc. - Product Pipeline Review - 2014’...

JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 31-page report is available in PDF from $1500. JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘JCR Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014’...

Histocell S.L. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Histocell S.L. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 23-page report is available in PDF from $1500. Histocell S.L. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Histocell S.L. - Product Pipeline Review - 2014’, provides an overview of the Histocell S.L....

Pantarhei Bioscience BV - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Pantarhei Bioscience BV - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 33-page report is available in PDF from $1500. Pantarhei Bioscience BV - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Pantarhei Bioscience BV - Product Pipeline Review - 2014’, provides an over...

Pharminox Limited - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Pharminox Limited - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 25-page report is available in PDF from $1500. Pharminox Limited - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Pharminox Limited - Product Pipeline Review - 2014’, provides an overview of the Pharmi...

Rhizen Pharmaceuticals SA - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Rhizen Pharmaceuticals SA - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 29-page report is available in PDF from $1500. Rhizen Pharmaceuticals SA - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Rhizen Pharmaceuticals SA - Product Pipeline Review - 2014’, provides a...

Supratek Pharma Inc. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Supratek Pharma Inc. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 28-page report is available in PDF from $1500. Supratek Pharma Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Supratek Pharma Inc. - Product Pipeline Review - 2014’, provides an overview of t...

Achaogen Inc. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, Achaogen Inc. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 30-page report is available in PDF from $1500. Achaogen Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Achaogen Inc. - Product Pipeline Review - 2014’, provides an overview of the Achaogen Inc.’s ...

AbGenomics International, Inc. - Product Pipeline Review - 2014

Recently added to the BioPortfolio report store, AbGenomics International, Inc. - Product Pipeline Review - 2014 is a new report from Global Markets Direct published on 2014-09-29. This 28-page report is available in PDF from $1500. AbGenomics International, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘AbGenomics International, Inc. - Product Pipeline Review - 2014...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks